Development of Validation and Stability Indicating Method of Anti-Hiv Dolutegravir Drug and Its Related Impurities by Using RP-HPLC
doi 10.35248/2157-7064.20.11.426
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Longdom Group